UBI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.47%

Insider Buying (Last 12 Months): A$53,050.14

Insider Selling (Last 12 Months): A$0.00

Universal Biosensors Insider Trading History Chart

Universal Biosensors Share Price & Price History

A^$0.00

+0.30 (1.20%)

As of 05/13/2020 01:00 AM ET

Move Your Money Before May 22

From Stansberry Research | Ad

The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.

Here's where Dr. David Eifrig says to move your money immediately.

Universal Biosensors Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
3/25/2024	Craig Coleman	Insider	Exercise	1,000,000	A$0.20	A$200,000.00
12/11/2023	Graham McLean	Insider	Buy	75,000	A$0.20	A$14,925.00
9/11/2023	Craig Coleman	Insider	Buy	100,000	A$0.22	A$22,000.00
6/30/2023	David Hoey	Insider	Buy	95,983	A$0.17	A$16,125.14
3/14/2023	Graham McLean	Insider	Buy	150,000	A$0.25	A$37,500.00
12/12/2022	Graham McLean	Insider	Buy	200,000	A$0.23	A$46,000.00
11/16/2022	Craig Coleman	Insider	Buy	150,000	A$0.24	A$36,450.00
8/17/2022	Craig Coleman	Insider	Buy	200,000	A$0.28	A$56,000.00
5/12/2022	Graham McLean	Insider	Buy	100,000	A$0.50	A$50,000.00
11/5/2021	Craig Coleman	Insider	Buy	1,378,757	A$0.74	A$1,016,143.91

Move Your Money Before May 1

From Stansberry Research | Ad

Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?

Click here to get the full story before May 1.

SEC Filings (Institutional Ownership Changes) for Universal Biosensors (ASX:UBI)

39.66% of Universal Biosensors stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices used in healthcare (point-of-care), wine, food, and agriculture industries in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin; and Sentia wine testing products, such as free SO2, malic acid, glucose, and fructose. It also offers non-diagnostic laboratory services and performs coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a test strip and a meter to be used for the detection and monitoring of diabetes in non-humans. Universal Biosensors, Inc. was incorporated in 2001 and is based in Rowville, Australia.

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

10,006 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

8.55%

Beta

0.92

Who are the company insiders with the largest holdings of Universal Biosensors?: Universal Biosensors' top insider investors include:
Craig Coleman (Insider)
David Hoey (Insider)
Graham McLean (Insider)
Learn More about top insider investors at Universal Biosensors.